Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal β-oxidation

35Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The effects of the persistent peroxisome proliferator, perfluorodecanoic acid (PFDA), on growth, feed intake and the enzyme activities associated with peroxisomal β-oxidation were studied in female Sprague Dawley rats. Rats received one of six levels of PFDA (0, 0.3, 1.0, 3.0, 10.0 or 30.0 mg/kg/injection) in four IP doses at 2-week intervals. Rats with cumulative doses of ≤ 12.0 mg/kg did not differ from control rats in growth or feed intake, while rats receiving cumulative doses of ≥40 mg/kg lost weight and decreased their feed intake. Rats which received cumulative doses between these levels increased their feed intake but did not significantly alter their body weight. Total peroxisomal β-oxidation was decreased in a dose-related manner, whereas the liver to body weight ratio and the activities of individual enzymes comprising the peroxisomal β-oxidation system, namely fatty acyl-CoA oxidase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and thiolase, were increased. This study clearly shows that the inhibition of peroxisomal ß-oxidation by PFDA is not reflected in the in vitro measurement of the individual enzyme activities comprising this pathway. © 1992 Springer-Verlag.

Cite

CITATION STYLE

APA

Borges, T., Robertson, L. W., Peterson, R. E., & Glauert, H. P. (1992). Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal β-oxidation. Archives of Toxicology, 66(1), 18–22. https://doi.org/10.1007/BF02307265

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free